Control analysis of the eukaryotic cell cycle using gene copy-number series in yeast tetraploids by Annette A Alcasabas et al.
Control analysis of the eukaryotic cell cycle using
gene copy-number series in yeast tetraploids
Alcasabas et al.
Alcasabas et al. BMC Genomics 2013, 14:744
http://www.biomedcentral.com/1471-2164/14/744
Alcasabas et al. BMC Genomics 2013, 14:744
http://www.biomedcentral.com/1471-2164/14/744RESEARCH ARTICLE Open AccessControl analysis of the eukaryotic cell cycle using
gene copy-number series in yeast tetraploids
Annette A Alcasabas1,2,3†, Michaela de Clare1,2†, Pınar Pir1,2,4 and Stephen G Oliver1,2*Abstract
Background: In the model eukaryote, Saccharomyces cerevisiae, previous experiments have identified those genes
that exert the most significant control over cell growth rate. These genes are termed HFC for high flux control.
Such genes are overrepresented within pathways controlling the mitotic cell cycle.
Results: We postulated that the increase/decrease in growth rate is due to a change in the rate of progression
through specific cell cycle steps. We extended and further developed an existing logical model of the yeast cell
cycle in order elucidate how the HFC genes modulated progress through the cycle. This model can simulate
gene dosage-variation and calculate the cycle time, determine the order and relative speed at which events
occur, and predict arrests and failures to correctly execute a step. To experimentally test our model’s predictions,
we constructed a tetraploid series of deletion mutants for a set of eight genes that control the G2/M transition.
This system allowed us to vary gene copy number through more intermediate levels than previous studies and
examine the impact of copy-number variation on growth, cell-cycle phenotype, and response to different
cellular stresses.
Conclusions: For the majority of strains, the predictions agreed with experimental observations, validating our
model and its use for further predictions. Where simulation and experiment diverged, we uncovered both novel
tetraploid-specific phenotypes and a switch in the determinative execution point of a key cell-cycle regulator, the
Cdc28 kinase, from the G1/S to the S/G2 boundaries.
Keywords: Cell cycle, Control analysis, Copy number variation, Logical model, Tetraploid, YeastBackground
In constructing a systems-level model of the eukaryotic
cell, insight can be gained by considering the system
from the ‘top down’, and populating the model with only
the most important components, i.e. those exerting the
greatest degree of control over cellular processes. The
approach can be mathematically formalised using
Metabolic Control Analysis (MCA) [1,2] which de-
scribes how the relationship between pathway fluxes
and reagent concentrations depends on the network
properties. More recently, the approach has been used
to describe not only metabolic, but also signalling net-
works [3]. The relative degree of control which a given* Correspondence: sgo24@cam.ac.uk
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reproduction in any medium, provided the orprotein product exerts on a pathway is quantified via its
flux control coefficient:
CJE ¼ ΔJ=J
.
ΔE=E
That is, the control coefficient CE
J describes the
change in the flux J at steady state that results from the
relative perturbation of an effector E and so represents
the fraction of control which the particular effector ex-
erts over the total flux. To describe, as we seek to here,
the relative importance of given genes within the gen-
ome of the model eukaryote Saccharomyces cerevisiae,
and constrain the value of a given protein’s (i.e.
effector’s) control coefficient, complementary experi-
ments must be performed: 1. changing the flux through
the pathway and measuring the impact upon protein
concentration (described in [4,5]); 2. changing the pro-
tein concentration and measuring the impact upon the
pathway flux.ral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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periments using the set of heterozygous deletion mu-
tants for all protein-encoding genes in the yeast genome
[6,7]. Through the measurement of growth rates in
batch culture, and competition experiments in continu-
ous culture, we identified a set of genes in S. cerevisiae
for which the heterozygous deletion mutants exhibit a
growth rate significantly different from that of the wild
type (WT). Together, these haploinsufficient (the hetero-
zygous mutant displays slower growth than the WT; HI)
and haploproficient (faster than WT growth when het-
erozygous; HP) genes form a set of ‘high flux-control co-
efficient’ (HFC) genes which, together with the essential
genes, exhibit significant control over the cell growth
rate and are candidates for inclusion in our ‘coarse-
grained’ cell model.
These previous experiments, however, only explored
the flux at 100 and 50 percent of WT gene dosage. To
be able to study the variation in flux at more intermedi-
ate gene dosages, and hence more precisely measure the
values of the control coefficients, we analysed the effect
on growth of sequential deletions of alleles in tetraploid
yeast cells. With four copies of the genome in the tetra-
ploid, we are able to construct mutants having 0, 25, 50
and 75% of WT gene dosage (corresponding to 0, 1, 2
and 3 copies of the gene, respectively) for each of eight
HFC genes comprising two signal transduction pathways
controlling the G2/M cell cycle transition. In doing so,
we followed the approach taken in a previous study,
which measured flux control coefficients for the trypto-
phan biosynthetic pathway [8]. Allowing an increased
range of flux variation, without employing either overex-
pression or non-native promoters, the tetraploid system
is ideal for the determination of flux control coefficients.
However, widespread adoption of the approach has been
frustrated by the difficulty of constructing tetraploids,
and we believe this paper reports the first systematic
study of tetraploid series for pathway analysis since the
original work by Niederberger et al. [8].
Several cellular processes, such as transcription and
translation, are particularly enriched for high-flux-
control genes. For instance, genes encoding subunits
of the 80S ribosome are strongly haploinsufficient,
while those encoding components of the general tran-
scription factor TFIID complex are enriched for hap-
loproficiency [7]. The S. cerevisiae cell cycle, too, is
enriched for HFC genes [9], and we propose that the
deviation from the wild-type growth rate observed in
heterozygotes is due to the cell progressing through
the cell cycle at an accelerated/decelerated rate. Thus,
studying the growth rate phenotype is equivalent to
studying the cell cycle period. In the present work, in
order to study the interaction of the growth pheno-
types and cycle periods of HFC genes, we focussedour tetraploid studies on a cell cycle checkpoint mod-
ule for which each member is encoded by an HFC
gene (Figure 1). The module consists of two mitogen-
activated protein kinase (MAPK) cascades enriched
for HFC genes: the cell wall integrity (CWI) and the
high osmolarity glycerol (HOG) pathways, which co-
regulate mitotic entry in response to stresses such as
temperature and osmolarity. The pathways converge
on the complex of the cyclin-dependent kinase
Cdc28p and the G2 cyclins Clb1p and Clb2p, the
presence of which are required to drive the G2-to-M
phase transition. These pathways represent two of at
least six distinct S.cerevisiae MAP kinase cascades
which control the regulation of gene transcription in
response to extra- and intra-cellular stresses and sig-
nals. They are highly conserved, both structurally and
functionally, among eukaryotes [10,11].
The first cascade, the CWI pathway, controls the
process of cell wall synthesis as the cell changes volume
and shape during the cell cycle and in response to heat
and hyperosmotic stress or cytoskeletal perturbation
[11,12]. These stresses are sensed by different compo-
nents of the pathway and result in activation of the
Slt2p kinase [13] and the eventual remodelling of the
cell wall. When activated, the pathway also contributes
to G2/M cell cycle arrest. Genetic evidence suggests
that this occurs by blocking the activity of the Mih1
phosphatase [14], which is required to remove inhibi-
tory phosphorylation on tyrosine 19 of Cdc28p. In con-
trast, the cell responds to hyperosmolarity by activating
the high osmolarity glycerol (HOG) pathway, which
leads to a higher intracellular glycerol concentration to
restore the osmotic gradient. Elevated glycerol produc-
tion is mediated by the Hog1 kinase and involves both
increased gene expression and a metabolic response
[15,16]. In addition, activation of this pathway leads to
transient cell cycle arrest until the right glycerol con-
centration is reached. Hog1p-mediated arrest at the G2/
M transition occurs, in part, by triggering the morpho-
genesis checkpoint. Hog1p phosphorylates Hsl1p [17],
which (when a bud is correctly formed) is present at the
bud neck and recruits and degrades Swe1p [18,19]. The
Swe1p kinase negatively regulates Clb2p-Cdc28p activ-
ity by binding to the complex and phosphorylating
Cdc28p on tyrosine 19 [20]. The morphogenesis check-
point thereby works to delay mitotic entry until a crit-
ical bud size is reached, and defects in the actin
cytoskeleton or septin assembly are overcome. Cells
arrested by the checkpoint are significantly elongated
since polarised growth persists during budding, instead
of isotropic growth resuming within the bud [21]. In
contrast, overriding the checkpoint interferes with cor-
rect nuclear segregation and results in an accumulation
of binucleate mother cells [18,22].
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Figure 1 Regulation of the G2/M transition in the yeast cell cycle. Diagram of the eight gene products which form the checkpoint module
linking the osmotic stress response (through the Hog1 MAP kinase) and the cell wall integrity pathway (through the Slt2 MAP kinase) to the
regulation of the cell cycle G2 to mitosis transition.
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Copy number variation affects growth rate, viability, and
cell cycle progression, and in silico simulations are
predictive of in vivo behaviour
In an attempt to predict the trends in phenotypic vari-
ation that we might observe in the tetraploid mutant
series, we constructed a logical model of the S.cerevisiae
cell cycle and simulated the effects of deleting the HFC
G2/M checkpoint genes. Our model is based on that of
Fauré et al. [23], which incorporates 27 genes and 4 cell-
cycle states as nodes, the Boolean state of which is gov-
erned according to logical expressions updated in
discrete, equal-length, time-steps. The Fauré et al. model
is, in turn, an adaptation of an earlier differential-
equation cell cycle model [24].
We extended the Fauré et al. model, adding a further
30 cell-cycle-related genes (Figure 2 and see Additional
file 1: Table S1 and Model S1), all of which had been
identified as HFC in our diploid screen [7]. The logical
relationships linking in the new nodes were inferred
from published data on the wiring of the S.cerevisiae cell
cycle [25]. We also added several further self-contained
modules (representing the spindle checkpoint, and the
DNA damage-response checkpoint), which can beselectively incorporated into simulations. The model
states are associated, as in Fauré et al. [23], with cell
cycle stages. Briefly, G1 begins at START with the acti-
vation of the G1 cyclins and their associated species, cell
mass being at its lowest level, and the cell in an
unbudded state. Levels of the Cdc28p/Clb complex are
low, due to the presence of B-type cyclin inhibitors, and
the genes in the morphogenesis checkpoint (the species
we have studied here) are not active, due to the lack of a
bud. S and G2 phases are characterised by the degrad-
ation of the B-type cyclin inhibitors and the consequent
accumulation of Clb1p and Clb2p, the emergence of a
bud, and the subsequent activation of the morphogenesis
checkpoint genes. The relevant hallmarks of M phase
are the completion of the budding process, and thus the
inactivation of the morphogenesis checkpoint and the
gradual decline of B-type cyclin levels as the cell pro-
ceeds through the exit from mitosis following cytokin-
esis. Using the signature features thus defined, the
number of time-steps the simulation spends in each cell
cycle phase may be counted and, consequently, a cell
cycle profile assembled. Profiles for each of the deletion
strains were calculated by counting the number of time-
steps, out of 10,000, spent in each stage. Results were
Figure 2 Extended model of the yeast cell cycle. New modules added to the logical model of the yeast cell cycle developed by [23],
represented in BioTapestry [26].
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normalised to the WT profile, giving the relative propor-
tions of cells in G1, G2/S and M.
A novel feature of our extended model enables its
use to predict the phenotypic effect of gene copy num-
ber variation. The extended model’s functionality al-
lows it to simulate the deletion of a subset of copies of
a given gene, by defining the probabilities with which
these species are located within each logical expression
(see Methods). A similar mechanism allows us to
simulate the effects of inhibitors, DNA-damaging
agents, or osmotic stress. The model displays a robust-
ness similar to that of the original model of Fauré et al.
[23]. WT cell cycle progression is similar, though pro-
gression times for different stages are altered due to
the presence of additional, often intermediate, gene
products. Using this model, we predicted both the cell-
cycle period (and, consequently, growth rate; Figure 3a)
and progression (Figure 4 & Additional file 1) for each
member of the tetraploid series by simulating mutants
having 0, 25, 50 and 75% of WT gene dosages (here-
after referred to as null-, single-, two- and three-copy,
respectively). The model also allows us to identify the
precise mechanisms underlying phenotypic changes,
since we can follow the relative amount of time spent
at each step of the cell cycle and note the particular
nodes whose activation/inhibition is compromised inthe deletant relative to the wild type. It is important to
emphasise that, in simulations employing the model,
time is measured in fractions of a cell cycle, rather
than chronological time. This biological measure of
time is probably more relevant to the study of gene-
dosage effects since growth rate, and hence the cycle
time in minutes, can alter according to the identity or
supply of specific nutrients or other physiological
factors.
Construction of tetraploid series for HFC genes
We created tetraploid deletion series for each of the
eight genes under consideration by mating the relevant
mating-competent diploid deletion mutants, as de-
scribed in Methods. We believe that this approach rep-
resents a powerful tool in probing flux through
metabolic and signalling pathways to a more precise
degree than traditional diploid/haploid screens. Using
RT-PCR, we have quantified the effect of incrementally
deleting the copies of a gene in the tetraploid on both
the target gene mRNA levels, and those of the geneticin-
resistance kanMX cassette with which it was replaced
(see Methods). These determinations confirmed that, for
each of the eight tetraploid series, deletion of all four
copies completely ablated gene expression and, for the
intermediate copy-number strains, the gene mRNA
levels approximate the expected 25, 50 and 75%
Figure 3 Comparison of model prediction and in vivo data for tetraploid growth rates and cell-cycle distributions. a) growth rates
relative to wild type for the strains within each of our tetraploid deletion series; experimental data (in liquid medium: black dashed lines, squares;
on solid medium: red solid lines, circles) is compared to model predictions (grey solid lines, triangles); b) cell cycle distributions of the tetraploid
deletion series measured by flow cytometry; proportion of cells with G1 (leftmost peak) and G2/M (rightmost peak) DNA content are shown.
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tetraploid (see Additional file 1).
Tetraploid yeast strains have been reported to have
less stable genomes than diploids or haploids [27,28],
particularly over long periods in stationary phase [29].
Any chromosome loss would render the series non-
isogenic and introduce confounding factors, such as
the change in dosage of many other genes, and wouldimpact on the measured growth rate of the strain. To
avoid this, we measured the DNA content of all tetra-
ploid strains prior to making frozen stocks, all pre-
cultures were inoculated directly from such stocks,
and sub-cultured only once. All analyses were per-
formed in YPD medium and no batch culture was
kept for more than 48 hours. Our flow cytometry re-
sults (Figure 3b) demonstrate that no reduction in
Figure 4 Comparison of model predictions and imaging flow-cytometry measurements of the quantitative cell cycle profiles. a) HSL1,
b) CLB2, c) CDC28 tetraploid deletion series; d) CDC28 diploid series. Proportion of cells relative to WT in G1 (experiment: grey squares; model
prediction: black squares) and S/G2 (experiment: grey triangles; and model prediction: black open triangles). e) Relative accumulation in the G1 or
G2 phase of the cell cycle for the diploid cdc28/cdc28 + cdc28-as1 strain with increasing inhibitor concentration, f) Effect of increasing
concentrations of 1 nm-PP1 specific inhibitor on the growth rate relative to the untreated cdc28/cdc28 + cdc28-as1 strain and to cdc28/cdc28 +
CDC28 treated with the same inhibitor concentration, with mRNA level/growth rate relationships from the tetraploid series indicated
for comparison.
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ditions. To further underscore the genomic stability
of our tetraploids in exponential phase, we grew a
pool of strains in chemostat continuous culture in
a complex, but chemically defined, medium [30] for a
period of 4 days (30 to 35 generations) and observed
no reduction in DNA content (data not shown).Exploiting tetraploid series to probe the impact of gene
dosage on cell cycle phenotypes
HOG1 and MIH1 mutants display no phenotype in the
absence of external stress, but the HOG1 deletion series
displays a non-linear response to osmotic stress
In both simulations and experiments, variation in HOG1
gene copy number did not affect the growth rate
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(Additional file 1), and incremental deletions of the
genes also had no effect on cell cycle progression
(Figure 3b). Similarly, MIH1 reduction in the tetraploid
had no effect on either growth rate or cell cycle distribu-
tion, consistent with previous results for mih1 null hap-
loids [31] and, as for HOG1, the MIH1 simulations agree
with our experimental observations. This lack of pheno-
type is to be expected, as the osmolarity signalling path-
way should be inactive in the absence of osmotic stress.
Stress treatments, however, elicited significant pheno-
typic responses in the HOG1 series. In particular, we
observed a consistent, non-linear relationship between
salt stress tolerance and HOG1 gene dosage: the three-
copy tetraploid is significantly more resistant to stress
than the WT (median p-value across stresses = 0.007,
one-sided t-tests); the two-copy mutant is equally as
fit as the WT (average p-value for deviation from WT
growth = 0.14), and the null mutant is typically more
sensitive (median p-value = 0.01, one-sided t-tests;
Figure 5) in both liquid and solid cultures. The hog1 null
tetraploid is roughly twice as sensitive as the
intermediate-dosage strains at 0.5 and 1 M NaCl
(Figure 5) and inviable at 2 M (data not shown), as are
the null diploid and haploid mutants [32,33].
This suggests that the HOG1-coordinated response to
stress in the WT may, in effect, be an ‘overreaction’ in
that S.cerevisiae can tolerate stresses with less than WT
levels (in this case, as low as 25% of the WT level) of
Hog1p activity. The decreased Hog1p levels allow
the cell cycle to proceed, rather than arresting it during
the stress response. The HOG1 pathway is at the core ofFigure 5 Response of the HOG1 deletion series to a range of stress tr
mutants. Liquid growth profiling, fitness measured as the growth rate in tthe S.cerevisiae stress response, and we hypothesise that
it may have evolved to be hyper-responsive, given the
extreme stresses to which yeast is exposed in the wild.
This concurs with the findings of [34] and [35] who have
shown that the degree of up-regulation of the HOG1
pathway cannot keep pace with a ‘ramped’ increase in
osmotic stress. We suggest that the cell may compensate
for this failing by overreacting on first exposure to salt
stress, with the result that the initial pathway activation
level might be sufficiently high to manage a ramp in
stress until the Hog1 response can be recalibrated. This
is also consistent with previous studies showing that a
metabolic response to osmotic stress occurs immediately
and is essential, while the Hog1p-mediated transcrip-
tional response is secondary [16,36]).
Additionally, the hog1/hog1/hog1/hog1 null tetraploid
is highly sensitive to the ER-stress and G1-arrest–indu-
cing [37] agent tunicamycin (Figure 5). This is congruent
with haploid mutant results (deletion sensitises cells,
whilst overexpression confers resistance; [38]) and sup-
ports the idea that Hog1p may be required for proper
G1 progression. In particular, HOG1 may be implicated
in the synthesis of G1 cyclins on exit from G0 [38], al-
though HOG1 is also implicated in the late stages of the
ER stress response, where it is thought to stabilise the
autophagy protein Atg8p [39].
SLT2 depletion severely compromises growth in the
tetraploid
Modelling and experimental results are in quantitative
agreement for mutants having at least one copy of the
SLT2 gene (but fewer than the WT) – strains groweatments, showing the resistance of the individual deletion
he stressed condition relative to untreated growth, relative to the WT.
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the in vitro and in silico cell cycle profiles of the partial
slt2 deletants are comparable to the WT – suggesting,
interestingly, that the increased growth rate is not due to
the cell speeding through one particular cell cycle step,
as we observed in other mutants, but rather that all
stages (or, at least, both G1 and G2; Figure 3b) proceed
at an accelerated rate. As well as the G2/M transition we
have studied here, the SLT2 pathway targets the hetero-
dimeric SBF (Swi4-Swi6 cell-cycle box binding factor)
transcription factor involved in the G1/S transition [12];
the slt2 deletion appears to be simultaneously affecting
both transitions to produce this effect.
Experimentally, we made the novel observation that
the complete absence of SLT2 severely compromises fit-
ness in the tetraploid state. The tetraploid null mutant is
very slow growing, forming small colonies on solid
medium, and failing to achieve exponential growth after
20 hours in liquid medium; whereas the diploid null mu-
tant is viable. The strongly fitness-compromised tetra-
ploid null mutant population consists almost entirely of
cells arrested in G1 (Figure 3b), suggesting that either
the SLT2 pathway impacts upon the G1/S more strongly
than the G2/M transition or that these cells have a very
slow exit from the previous stationary phase.
In contrast to what we observed for tetraploids, null
slt2 haploids and diploids are completely viable. This
suggests a tetraploid-specific basal level of activation of
the Slt2p-mediated cell wall integrity (CWI) pathway.
Consistent with this, we found that the slt2 null tetra-
ploids completely fail to grow when subjected to heat
(37°C) or cold (21°C) stresses that activate the CWI
pathway (data not shown). It has been suggested that
the decreased ratio of cell surface area to cell volume in
tetraploid cells leads to altered regulation of cell surface
components [40]. While cell size measurements using
imaging flow cytometry show that the cell volume of the
WT tetraploid is roughly 60% larger than that of the
WT diploid, this corresponds to a cell surface area in-
crease of only 36% (Figure 6c,d). In the study by Wu
et al.[40], tetraploids were compared to isogenic hap-
loids and it was found that the increased cell size leads
to differential expression of genes encoding components
of the cell wall, plasma membrane, extracellular matrix,
and their intracellular regulators. These transcriptional
changes are partly attributed to an increase in MAPK
signalling through the mating and filamentation MAPK
pathways, the results also showed that the SLT2 mRNA
is two-fold more abundant in tetraploids than haploids
[40].
We therefore subjected isogenic WT haploids, dip-
loids, and tetraploids to a number of cell-wall-specific
stresses (sorbitol, calcofluor white, and salt). Tetraploids
were no more sensitive to sorbitol and calcofluor whitethan the isogenic diploid or haploid strains (see
Additional file 1). However, we did find that WT tetra-
ploids are more sensitive to 1 M salt than WT diploids
(data not shown). This suggests that, like the Slt1p-
mediated MAPK pathway, the Hog1p pathway may also
be constitutively active at a low level in tetraploids,
which can also explain the overreaction to salt stress by
WT tetraploids, discussed above, which was not ob-
served with WT diploids (data not shown).
SWE1 deletion mutants exhibit faster growth
For SWE1, reduction in copy number from four (WT
level) to three, resulted in an approximately 18% in-
crease in growth rate (Figure 3a). Growth remained rela-
tively constant at this increased rate upon further
reduction in copy number, and viability remained com-
parable to the WT in all cases (Additional file 1). How-
ever, whilst the model’s results for swe1 deletions predict
a similar increase in growth rate for the three- and two-
copy mutants, the simulated growth rate subsequently
decreases with decreasing copy number (i.e. for the
single-copy and null mutants). Since the tetraploid
phenotype is congruent with SWE1 haploproficiency in
the diploid, the fault seems to lie with the model, rather
than any difference between the diploid and tetraploid
cell cycles.
Deletion of HSL1 affects growth
For HSL1, both in vivo and in the model’s simulation,
growth rate decreased monotonically with successive de-
letions, with the null mutant achieving only ~65% of the
WT rate (Figure 3a). The lower copy number strains ex-
hibit significantly decreased viability, with PI staining in-
dicating death rates of up to 10% of the population
compared to 1.5% for the WT (see Additional file 1).
Further reductions in copy number result in increasing
numbers of cells with a G2 DNA content (Figure 3b).
Imaging flow cytometry on an asynchronous culture of
the hsl1 null tetraploid showed that the combined pro-
portion of S-phase and G2 cells in the population is
51%. This is about 1.5 times that found in WT tetra-
ploids (35% of cells in S phase and G2; Figure 4a and
Additional file 1) and is in excellent quantitative agree-
ment with our modelling results. Furthermore, the null
tetraploid is sensitive to treatment with hydroxyurea
(data not shown), which inhibits ribonucleotide reduc-
tase and so causes S-phase arrest [41]. This is consistent
with the phenotype of hsl1 haploids, which show a very
slow recovery from HU-induced S-phase arrest due to
the inefficient degradation of accumulated Swe1p [42].
We had previously identified HSL1 as haploinsuffi-
cient, and the growth rate of the tetraploid two-copy
mutant (approximately 90% of the WT rate) is compar-
able with our results for the growth of the heterozygous
Figure 6 Cell morphology of the tetraploid series. a) Cell lengths of the hsl1, clb2, cdc28 mutant and WT tetraploid strains and cdc28 diploid
strains, plotted against percentage gene dosage, G1 cells (white bars), S/G2 phase cells (grey bars), Mitotic cells (grey bars); b) images of WT,
cdc28-DAmP and hsl1 null tetraploid strains; c) cell areas of WT tetraploid and diploid strains; and d) projected volumes of WT tetraploids relative
to WT diploids. Measurements from two independently isolated WT tetraploid strains are shown in a, c, and d.
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demonstrated that single-copy and null hsl1 tetraploids
display an abnormal, elongated, morphology (Figure 6a
and 6b) similar to that reported for null haploids in cer-
tain genetic backgrounds [21]. In other strains, the elon-
gated morphology and G2 accumulation phenotypes of
hsl1 null haploids are only seen in combination with
modest overexpression of Swe1p [18]. These findings
suggest that the G2/M transition is very sensitive to thebalance between Swe1p and Hsl1p and that the critical
level of Hsl1p is above a single copy (>25% gene dosage)
in the S288C-derived tetraploid strain.
Phenotypes of the B-type cyclin deletions differ
significantly
A particularly significant prediction that emerged from
our initial modelling was the divergent phenotypes of
deletions of the two B-type cyclin genes, CLB1 and
Alcasabas et al. BMC Genomics 2013, 14:744 Page 10 of 17
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the null and the single-copy mutants). This prediction
emerged directly from the fact that, despite being other-
wise wired into the cell cycle identically, CLB2 degrad-
ation by the APC/C begins earlier than degradation of
CLB1 (reviewed in [43]), hence the response to reducing
the CLB2 copy number is more pronounced. Model pre-
dictions were subsequently confirmed experimentally,
with the measured growth rates in excellent quantitative
agreement with our simulation results (Figure 3a).
We previously identified CLB1 as haploproficient and
CLB2 as haploinsufficient in diploid cells, and our tetra-
ploid findings are consistent with this. Any partial or full
deletion of CLB1 leads to a significantly faster growth
rate (approximately 20% faster; Figure 3a) than WT, with
strain viability comparable to that of WT. For CLB2, the
three- and two-copy tetraploids have a growth rate simi-
lar to WT. However, at the single-copy and null CLB2
gene dosages, cells exhibit a significant reduction in both
viability and maximum growth rate due to a delay in the
G2/M transition (Figures 3b and 4b; Additional file 1).
This suggests that there exists a threshold level, probably
between the single- and two-copy gene dosages (i.e. 25-
50% WT dosage), below which the concentration of the
CLB2 protein product cannot drop if proper cell func-
tion is to be maintained. In this case, the haploinsuffi-
ciency of CLB2 in the diploid would be due to the
heterozygous deletion taking the concentration below
this threshold dose. This suggests that the effect upon
protein levels of deleting one copy in the diploid is more
severe than that of deleting two of four copies in the
tetraploid. It should be noted, however, that the simu-
lated null mutant is slightly more unfit than is observed
in vivo. Moreover, the simulated variation in the cell-
cycle profile due to the G2/M delay is also more extreme
than that observed in vivo (Figure 4b).
Flow cytometry demonstrated that, whilst the single-
copy and null clb2 deletion mutants suffer pre-mitotic
cell cycle arrest, deletions of CLB1 have no effect on
cell-cycle progression (Figure 3b). The contrast in phe-
notypes is consistent with observations that, among the
four mitotic cyclins (Clb’s 1 to 4) in budding yeast,
Clb2p plays the major role at mitotic entry [44,45].
Clb2p uniquely localises to the bud neck during mitosis
[46], where it is required for the degradation of Swe1p
[47]. Mutations that prevent this localisation result in
G2/M delay and in cells with an elongated morphology.
This exactly corresponds to the phenotype in our tetra-
ploid deletant series (Figure 6a). All this is consistent
with the major function of CLB2 being within the mi-
totic cell cycle, whilst CLB1 plays the more significant
role in meiosis [48]. CLB1 is expressed mitotically [44]
and the faster cell cycle phenotype we observe is consist-
ent with the idea that more Clb2p-Cdc28 complexes areformed when the level of Clb1p, competing with Clb2p
for Cdc28p binding, is reduced.
CDC28
The simulated cell cycle arrest phenotype shows a bimodal
transition, dependent on CDC28 dosage
Cdc28p, the primary cyclin-dependent kinase in
S.cerevisiae, is integral to the regulation of both the early
and late stages of the cell cycle. Therefore, we expected
variation in CDC28 copy number to result in pro-
nounced, and potentially more complex, phenotypes
than the other HFC genes involved in the G2/M check-
point. Our simulations predict just this, with incremen-
tal deletions of the gene resulting in a severe and sudden
growth impairment. Additionally, the simulated cell-
cycle profile exhibited a bimodal transition (Figure 4c).
As gene dosage decreases from WT levels to 50% of
WT, increasing numbers of cells accumulate in G2,
reaching a maximum of ~2.5 x WT numbers in the two-
copy deletant. The relative number of cells in both the
G1 and M phases exhibits a commensurate decline, the
former being more pronounced than the latter. The sim-
ulations predict that inefficient spindle formation is the
major contributing factor to the slowed progression
through G2. This is consistent with experimental obser-
vations in haploid cells bearing cdc28 conditional muta-
tions that are arrested in G2, which are defective in
spindle pole-body separation [49,50].
Within the model, as gene dosage continues to de-
crease, the relative number of cells accumulating in G2
begins to decrease from this maximum, returning back
to WT levels at approximately 20% dosage. Simultan-
eously, the relative number of cells in G1 begins to rise,
returning to WT levels at single-copy gene dosage, until
(at the lowest gene dosages) the population is almost
completely arrested in G1. The transition in the cell
cycle phase in which cells accumulate reflects the chan-
ging relative impact of Cdc28p abundance upon G1 and
G2 progression as the copy number of the cognate gene
is varied. At the very lowest copy numbers, there does
not appear to be enough of the kinase available to allow
cells to proceed through G1 and initiate DNA replica-
tion. Above a certain threshold (roughly one quarter of
WT gene dosage), this impediment is overcome and cells
can enter into G2. Thereafter, from dosages from one-
quarter of WT to the WT-level, cell cycle progression
depends on the ability to pass through G2.
Experiment concurs with simulation but is limited by the
lowest viable CDC28 dosage
As a key cell cycle regulator, CDC28 is essential in hap-
loids, diploids, and tetraploids (data not shown). Conse-
quently, whilst we were able to construct tetraploids
with one, two and three gene copies, we could not
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achieve a lower concentration of Cdc28p, we con-
structed a tetraploid with a single cdc28-DAmP allele.
This allele contains no mutation in its coding region
but, owing to the insertion of an antibiotic resistance
marker at the immediate 3′ end of the coding sequence,
its mRNA is unstable [51]. In two independent isolates
of the cdc28-DAmP tetraploid, we measured the CDC28
mRNA concentration as 19% and 22% that of WT (see
Additional file 1). We also constructed a tetraploid with
one wild-type copy of CDC28 and one copy of cdc28-
DAmP, corresponding to a CDC28 mRNA concentration
of 36% (Additional file 1).
Experimentally, reduction in CDC28 gene dosage re-
sulted in progressively slower growth rates, reaching a
minimum of 60% of WT growth at the lowest dosage
(the DAmP allele-only strain). This was the greatest
growth-rate reduction observed for any of the genes
studied other than the quadruple deletion of SLT2.
Whilst the simulated drop-off in growth is more pro-
nounced, a marked increase in cell death was also ob-
served in experiments: only 90% of the population is
viable (see Additional file 1). This may account for the
quantitative disparity between model and observation,
since cell viability cannot be taken into account in the
simulations. This experimentally observed decline in via-
bility is consistent with the essentiality of CDC28; how-
ever, the decrease in tetraploid growth rate as gene
dosage is reduced is in direct contrast with our observa-
tions that the gene is haploproficient in the diploid.
At the lowest CDC28 expression levels that we were
able to obtain (i.e. ~20% mRNA dosage in the cdc28-
DAmP-only strain), cells accumulated with 8C (i.e. 2 N)
DNA content. Through imaging flow cytometry, we
identified these populations as pre-mitotic, S/G2 cells
(Figure 4c). The greatest degree of accumulation oc-
curred in the DAmP allele-only strains, where S and G2
cells accounted for 46% of the population, in contrast to
35% for the WT (see Additional file 1). This suggests
that these strains cannot efficiently transit from G2 to
mitosis. These observations were recapitulated in flow
cytometry results for a diploid series of CDC28 mutants,
i.e. a heterozygous diploid CDC28/cdc28 strain (50%
dosage), and a single copy of the cdc28-DAmP/cdc28
diploid (producing 20% of WT mRNA levels; Figure 4d
and Additional file 1). The tetraploid deletion series ex-
hibited increasingly elongated cell morphologies with de-
creasing gene dosage (the cdc28-DAmP/cdc28 having a
cell length 33% greater than that of WT; Figure 6a and
6b), a phenotype also observed for the cdc28-DAmP/
cdc28 diploid (approximately 20% longer than WT cells;
Figure 6a).
The model also predicts a population enriched in G1-
phase cells for CDC28 dosages lower than 20% (Figure 4cand 4d) when, we hypothesise, the level of Cdc28p goes
below the G1/S threshold as discussed above. We were
not able to verify this experimentally because we could
not isolate a cdc28-DAmP diploid or tetraploid with a
CDC28 mRNA concentration below 19%. We created
both cdc28-DAmP diploid and tetraploid strains by plas-
mid shuffling, with one mating cell carrying the WT
CDC28 gene on a plasmid. We observed a very low rate
of CDC28 plasmid loss for the resulting strains, suggest-
ing that having 19% of the WT CDC28 transcript level is
very close to the threshold required for cell survival.
G1 arrest occurs at very low Cdc28p activity levels
To generate levels of Cdc28p activity below 19% of WT,
we created a diploid cdc28/cdc28 yeast strain bearing
only the mutant cdc28-as1 (F88G) allele [49] on a
centromeric (single-copy) plasmid. This allele is sensitive
to the C3-1′-naphthyl PP1 (1 nm-PP1) derivative of PP1,
the Src-family-selective inhibitor [52], which can bind
only to the mutant Cdc28p, and not to any other (wild-
type) protein kinase. This allows the Cdc28p activity in
the strain to be titrated by varying the concentration of
inhibitor added. The effect upon the strain’s growth rate
of increasing concentrations of 1 nm-PP1, is shown in
Figure 4f. Comparing the growth rate at a given concen-
tration to that of the tetraploid deletion series allowed
us to estimate the degree of Cdc28p activity present in
each strain (Figure 4e).
Cell cycle profiling of this diploid mutant at high (μM)
concentrations of inhibitor therefore allowed us to probe
Cdc28p activities lower than could be obtained in the
tetraploid series (as discussed above), and confirmed the
model predictions. Cells accumulate in G2 upon treat-
ment with low concentrations of inhibitor (50 nM)
(Figure 4e). Based on the growth rate comparison, this
inhibitor dosage reduces Cdc28p activity to levels
equivalent to 25% of WT, and the degree of G2 accumu-
lation (126% compared with WT populations) is in
agreement with that observed for both diploid DAmP
strains having 20-27% of WT mRNA levels and for the
single-copy tetraploid strain (Additional file 1). However,
at higher inhibitor concentrations (500 and 5000 nM),
for which the growth rate indicates that Cdc28p activity
is reduced to well below 20% of the WT level, cells ar-
rest in G1 (Figure 4e). Furthermore, the degree of G1 ac-
cumulation (180% of WT levels at 5000 nM) is in
agreement with our simulation predictions.
Our stress-treatment data also support the bimodal
Cdc28p dose–response model. Significant sensitivity or
resistance to an arrest agent relative to the WT should
identify the precise stage within the cell cycle that vari-
ation in the dosage of a gene exerts its effect. This is the
dosage-variation equivalent to the ‘execution point’,
which was defined by Hartwell [53] as the first step at
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progression. Haploid CDC28-DAmP knockdown mu-
tants are sensitive to tunicamycin (which causes G1 ar-
rest) [37]; but our triple cdc28/cdc28/cdc28/CDC28
deletion mutant is more resistant to the drug than the
WT (see Additional file 1). This suggests that there may
be a phenotype transition, dependent on levels of
CDC28 below the ~25% of WT levels in the triple-
deletion tetraploid. This, combined with the lack of a
phenotype for cdc28 deletants under nocodazole treat-
ment (which causes G2 arrest by microtubule depoly-
merisation; see Additional file 1), would support our
model’s predictions that very low CDC28 copy numbers
may impact more strongly upon G1 than G2.Accumulation in G2 in the CDC28 deletion series is not
due to DNA damage
We sought to explore alternative causes of G2 arrest in
the CDC28 deletion series. In particular, several mecha-
nisms exist by which S.cerevisiae cells arrest cell cycle
progression in response to DNA damage (reviewed in
[54]). Using a modified version of our cell cycle model
that incorporates the probability of occurrence of differ-
ent forms of DNA damage, and the sensing and repair
pathways [9], we tested whether (in silico) deletion of
CDC28 activated the DNA damage response and
whether, conversely, cdc28 deletants were significantly
sensitive to disruption of this response. Simulation re-
sults suggest that the G2 arrest is independent of the
DNA damage response. To confirm this experimentally,
we searched for transcriptional up-regulation of
damage-response genes by using RT-PCR to determine
the levels of their transcripts. The mRNA levels of
DUN1, DUN7, RAD54, PLM2 and RNR3 (the down-
stream reporters suggested in [55]) were unchanged
from WT levels in either deletion series (see Additional
file 1).Discussion
Using a combined modelling and experimental ap-
proach, we have characterised the degree of control over
cell cycle period/growth rate for a complete checkpoint
module within the S.cerevisiae cell cycle. In the majority
of cases, the model predictions and observed phenotypes
in our tetraploid series were consistent with previous
findings in diploid and haploid strains, validating the
current work as an extension of our previous study of
high flux-control genes [6] and pathways [7], and
emphasising the significance of gene dosage variation ra-
ther than ploidy-specific effects. In particular, tetraploid
series of SWE1, CLB1, CLB2 and HSL1 had similar phe-
notypes to diploid mutants. These four genes exert a
high degree of flux control over the cell cycle, and theirsequential deletion had significant effects on growth
rate.
This present work looks at the effects of decreasing
the gene dosage of 8 cell cycle genes and complements a
previous study that looked at the upper limit of gene
dosage for 30 cell cycle genes in haploids [56]. Of the
five genes that were used in both studies, Moriya and
colleagues found that SWE1, CLB1, CLB2 had a low
limit of viable overexpression (<20 copies). In contrast,
CDC28 gene dosage was also limited but to higher num-
bers (around 80 copies), whereas there was no upper
limit of copy number observed for MIH1. Although they
had different phenotypes, the four genes that showed re-
stricted gene dosage in the Moriya study were all high
flux control genes in our experiments, whereas the mih1
deletion series behaved like wild type in terms of growth
rate and cell cycle profile. Both studies show the tight
regulation of gene expression for genes that impact on
G2/M CDK activity.
This present study also complements the increasing
amount of data on the relationship between gene dosage
variation and phenotype – in particular, the cataloguing
of drug sensitivity/gene CNV ‘fingerprints’ for tumour
cells [57], and recent transcriptome studies of yeast
strains adapted to different habitats to elucidate gene-
environment interactions [58].
The use of tetraploid series in flux-control analysis
Our work re-establishes the use of tetraploid deletion
series as a way of analysing the control of flux (following
[8]) and also facilitates the systematic study of gene dos-
age effects. By varying dosage through a series of clearly
resolved (~25% of WT mRNA dosage) steps, we can
capture dynamics obscured in gene-deletion studies. In-
deed, deleterious phenotypes upon copy-number vari-
ation may even be masked by complete gene deletion
due to the induction or derepression of alternative path-
ways [59]. The finer resolution provided by the tetra-
ploid deletion series has allowed us to experimentally
characterise the non-linearity of the relationship be-
tween gene dosage and the stress response - for example
the response of the HOG1 series to salt treatment – and
to begin to understand behaviours previously predicted
by dynamic modelling of MAPK pathways (see [60] for a
review).
However, a number of experimental refinements could
be made to allow more efficient construction of tetra-
ploid series, particularly in the creation of the mating-
competent precursor diploids. In this study, we sought
to keep our tetraploids isogenic with the strains studied
in [6], and therefore did not introduce additional select-
able markers during strain construction. Using this
method, we isolated the mating-competent diploids at
frequencies of 10-20% and 0.5% for the MATa/MATa
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analyses, however, efficiency would be significantly en-
hanced by the use of selectable markers under the con-
trol of the mating-pheromone promoters [61] to isolate
mating-competent diploids, and another marker to se-
lect tetraploids [27]. A further point to consider is the
inherent genome instability of yeast tetraploid strains
and to ensure that chromosome loss does not occur dur-
ing the course of an experiment. We addressed this by
minimising the amount of time our cultures spent in
stationary phase, an approach that we would recom-
mend in studies using tetraploid series.
Tetraploid-specific phenotypes
In terms of phenotypic analysis, it should be noted that,
in the current study, we measured the growth rate of in-
dividual strains during exponential phase in batch cul-
ture (~six generations). This is in contrast to our
previous work (in which the heterozygous diploid strains
were grown in continuous cultures in competition for
four days; 30–35 generations); thus, batch culture is a
less sensitive method of identifying growth rate vari-
ation. This may account for two genes – HOG1, MIH1 -
not showing any growth rate difference relative to WT,
in contrast to the diploid result. With this caveat, we
now consider the congruence between the predictions of
our logical model and the experimentally determined
phenotypes. In most modelling studies, deviations be-
tween a model’s predictions and the experimental obser-
vations contribute to the refinement and improvement
of the model. However, in this case, disagreement be-
tween experiment and simulation could also result from
behaviour unique to the tetraploid cell cycle, which was
not found in either the diploid or haploid cell cycles on
which the model was based. Where the architecture of
the tetraploid cell diverges from that of the diploid/hap-
loid, presenting external (non-cell cycle) perturbations,
our model is unable to correctly reproduce the pheno-
types observed.
We uncovered two such tetraploid-specific phenotypes
in the course of this study. The first is the growth-rate
trend of the SLT2 deletion series, which revealed a
tetraploid-specific basal level of activation of the SLT2
cell wall integrity pathway. We found that slt2 null tetra-
ploids are severely fitness-compromised even in the ab-
sence of cell-wall stress, whereas slt2 haploids and
diploids are completely viable. This is in agreement with
the findings of Wu et al. [40] that the decreased ratio of
the cell surface area to cell volume in larger cells leads
to altered regulation of cell surface components. In that
study, SLT2 mRNA was found to be two-fold more
abundant in tetraploids than in haploids [40]. The Slt2
signalling pathway is thought to respond to changes in
the plasma membrane when it is either stretched or hasaltered connections to the cell wall [11]. Thus it may be
that this pathway is always activated in tetraploids be-
cause of the limited cell surface area and, as a conse-
quence, Slt2p is required constitutively.
Reducing SLT2 copy numbers to intermediate levels
(in the two- and three-copy mutants) could prompt a re-
duction in this tetraploid-specific basal level of signal-
ling, thereby relaxing the cell-cycle regulation imposed
in the wild type. This might account for the increase in
growth rate relative to WT that we observed in these
intermediate deletion mutants. This growth advantage
was not observed in the diploid, supporting the conten-
tion that it is indeed a function of tetraploid-specific
pathway activation. Previously, three regulatory pro-
cesses were shown to be essential specifically in tetra-
ploids – homologous recombination, kinetochore
function, and spindle chromatid cohesion [27,62], and
our findings suggest that the CWI pathway is a fourth
essential process.
The CDC28 series also demonstrated tetraploid-
specific phenotypes: reduction of CDC28 copy number
in the tetraploid compromises fitness, whereas we previ-
ously found CDC28 to be haploproficient in the diploid
[7]. In the latter case, we attribute CDC28 haploprofi-
ciency (at least, in part) to the reduced activity of cell-
cycle checkpoints (in particular, the spindle checkpoint),
which are redundant in the absence of a cell cycle defect.
In the tetraploid, by contrast, we propose that these
checkpoints are required, and may not be omitted, such
that reduced levels of Cdc28p are disadvantageous to the
higher ploidy cell. It has been shown that, without any
perturbation, rates of spontaneous DNA damage and
syntelic kinetochore attachment are higher in tetraploids
than in diploids or haploids [27]. Consequently, regula-
tors of sister chromatid cohesion and the spindle/kineto-
chore functions are essential in the tetraploid [27,62]
and both these pathways explicitly require Cdc28p
activity.
Bimodal behaviour of the CDC28-series cell cycle profiles
The most intriguing and, we believe, novel prediction
emerging from our modelling is the bimodal transition
from G2 arrest, at CDC28 gene dosages above 25% of
wild type, to G1 arrest as the CDC28 dosage is lowered
below this threshold. This predicted behaviour is con-
sistent with a model wherein cyclin-dependent kinase
(CDK) activity progressively increases in one cell cycle,
and where a higher level of CDK activity is required at
the onset of mitosis than at the G1/S transition [63]. It
is difficult to determine the mechanism for this because
Cdc28p forms many different cell cycle complexes that
are each subjected to several levels of regulation. One
explanation for the greater requirement for G2/M CDK
activity is the different substrate specificities of the G1/S
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yeast. Accordingly, the complex of Cdc28p with the G1/
S cyclin, Clb5p, exhibits higher specificity for target pro-
teins (by approximately 100-fold) than does the Cdc28p-
Clb2p (G2/M phase) complex [64]. Thus, the threshold
level of Cdc28p at which G1/S targets are able to be
phosphorylated is lower than for G2/M. Another explan-
ation is that, for G1, it is the level of the G1 cyclins and
not Cdc28p that is limiting for G1/S progression. In sup-
port of this, Di Talia and colleagues [65] have shown
that overexpression of either CLN2 or CLN3 makes pro-
gression through G1 faster. G2 accumulation therefore
occurs whilst the Cdc28p concentration is above the G1/
S threshold level, and the phenotype switches to G1 ar-
rest when Cdc28p falls further, i.e. to a level beneath that
threshold. A third explanation is the presence of G2/M
CDK inhibitor Swe1p. Previous work from the Kitano
group [56,66] has shown that the gene dosage ratio be-
tween both inhibitors and activators at the G2/M transi-
tion are tightly maintained in a stable cell cycle. Our
results with the swe1, clb2 and hsl1 deletion series also
support this. We predict a lower G2/M requirement for
Cdc28p (and likewise Hsl1p and Clb2p) in a background
with lower than WT Swe1p levels.
We found that CDC28 essentiality imposes a limit on
the degree to which its mRNA levels could be reduced;
using the DAmP allele approach, the limit was ca. 19%
of WT levels, as discussed above. Hence, in our tetra-
ploid study, we could not perform an experimental test
of the model’s predictions for cell-cycle phasing at the
lowest levels of CDC28 dosage. However, our modelling
results were confirmed using an inhibitor-specific cdc28-
as1 diploid mutant. This demonstrates that novel, cor-
rect, predictions can be made by Boolean modelling of
the cell cycle.
Conclusions
Our work has re-established the use of tetraploid deletion
series as a way of analysing the control of flux and pro-
vides a new approach to the systematic study of gene dos-
age effects. By varying dosage through a series of clearly
resolved steps, we captured dynamics obscured in previ-
ous gene-deletion studies. An existing logical model of the
yeast cell cycle was greatly extended by adding a further
30 cell-cycle-related genes that we had previously shown
to exert a high degree of control over yeast growth rate.
We also added several further self-contained modules to
the model (representing the spindle checkpoint, and the
DNA damage-response checkpoint), which can be select-
ively incorporated into simulations. For the majority of
strains, the model’s predictions agreed with experimental
observations, validating our model and its use for further
predictions. Where simulation and experiment diverged,
we uncovered both novel tetraploid-specific phenotypesand a switch in the determinative execution point of a key
cell-cycle regulator, the Cdc28 kinase, from the G1/S to
the S/G2 boundaries. All of this demonstrates that novel,
correct predictions can be made by Boolean modelling of
the cell cycle.
Methods
Cell cycle modelling
Our model builds on that of Fauré et al. [23], who adapted
an earlier differential model [24] into a multi-valued lo-
gical format, thereby removing the requirement for quan-
titative parameter determination whilst preserving the
qualitative molecular relationships and model behaviour.
Beginning with this core model, we introduced a further
30 nodes to the original 22 defined by [23]. These repre-
sented the HFC genes, connected by approximately 150
new edges (see Additional file 1 for a list of the species
added and for an annotated version of the extended
model’s Python script). The logical relationships linking in
the new nodes were inferred from published data on the
wiring of the S.cerevisiae cell cycle [25]. Additional mod-
ules describing cell cycle checkpoints were developed as
described in [9].
Modelling gene copy number variation
The homozygous deletion of a gene was simulated by set-
ting the node representing the gene to zero within each
time-step. In modelling the heterozygous deletions (50%
of WT gene dosage, for example), the value of the node is
given by the following rubric:
If the logical requirements for node activation are not
satisfied: Node value = 0
If the logical requirements for node activation are
satisfied:
Node value = 0 with probability 0.5
Node value = 1 with probability 0.5
The latter was achieved through the use of a (pseudo-)
random number generator on the interval (0,1), with the
node set to zero for values less than 0.5, and one for
values greater than 0.5. Where the node is multi-valued
(as is the case for, e.g., CLB2), if the node value is not reset
to zero, its value is maintained at the level for which the
logical requirements are satisfied. Within a time-step, for
each occurrence of the node in a logical statement, an in-
dependent call was made to the random function to deter-
mine the node value within the expression. Similarly, for
0, 25 and 75% of WTgene dosages, the probability of node
value being reset to zero is 1, 0.75 and 0.25, respectively.
Modelling the growth rate
The WT cell cycle was simulated with a period of 31
time-steps, with a complete cycle defined (as in [23]) as
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through the activation of the CYTOKINESIS variable to
level 2, and, finally, the return of the value of MASS,
after cytokinesis, to one, which initiates the next START.
We defined a complete cytokinesis event as a run of
more than two successive time-steps having the CYTO-
KINESIS variable at level 2. To calculate the growth rate
of deletion strains, simulations were run over 10,000
time-steps and the number of complete cytokinesis
events counted. Results were averaged over 10,000 simu-
lations. Thus, the relative growth rate of a deletion strain
is given by the average number of time-steps to
complete its cell cycle divided by the length of the wild-
type cycle (31 time-steps).
Experimental methods
Tetraploid strain construction
Tetraploids were derived from the BY4743-based hetero-
zygous and homozygous diploid deletion collections [67].
Diploids were made homozygous at the MAT locus by
transformation with the pGal-HO endonuclease plasmid
[68] and pGal-HO induction following a protocol from
the Haber laboratory [69]. pGal-HO expression was in-
duced with 2% galactose for 40 minutes, cells were plated
out at a density of 2000 cells per 90 mm plate, and were
grown for 20–24 hours. This allowed us to screen a large
number of colonies by replica-mating to standard yeast
mating-type tester strains, followed by colony PCR to ver-
ify the presence of a single MAT allele (see Additional file
1: Methods for primers). Using this method, we isolated
MATa/MATa diploids at a frequency of 10-20% and
MATα/MATα diploids at a frequency of 0.5%.
Compatible diploid maters were mixed in liquid YPD
medium to allow them to mate and form tetraploids. The
WT tetraploid was the product of mating WT MATa/
MATa and WT MATα/MATα; the three-copy tetraploid
was constructed by mating a heterozygous diploid with a
WT; the two-copy by mating heterozygous diploids of
each mating type; the single-copy by mating one homozy-
gous and one heterozygous diploid; and the null mutant
(for the non-essential genes) by mating homozygous dip-
loid deletants of each mating type. Single-copy and cdc28-
DAmP tetraploid strains, and the diploid strain carrying
either the wild-type CDC28 or cdc28-as1 allele on a
single-copy plasmid were created as detailed in Additional
file 1: Methods. Tetraploid zygotes were visible after 3–
4 hours and were isolated using a micromanipulator
(MSM, Singer Instruments). The presence of both MATa
and MATα loci was verified by colony PCR, tetraploid
DNA content was verified by flow cytometry.
Flow cytometry
To analyse DNA content in tetraploid populations, cells
were harvested in mid-exponential phase (OD600 = 0.4 to0.5). For the diploid cdc28-as1 (F88G) strain, cells were
grown to exponential phase in YPD, harvested, and the
medium replaced with YPD plus the required concentra-
tion of inhibitor, and returned to 30C with samples
taken at 30 minutes, 1 hour, 2 hours and 3 hours there-
after. Cells were fixed and stained using the method of
[70]. We used a CyAn ADP analyzer (Beckman Coulter)
and Flow-Jo software (Treestar) to visualise DNA con-
tent distribution.
To make a distinction between G2 and S-phase cells
within populations having a 2N DNA content, we used
multispectral imaging flow cytometry according to a pre-
viously published protocol [71], but with the following
changes. Sytox-green-stained cells were resuspended in
phosphate-buffered saline at a concentration of 107
cells/ml prior to loading them into an Imagestream im-
aging flow cytometer (Amnis Corporation). 4000 images
of each strain were taken and analysed using the IDEAS
software package (Amnis Corporation). Cell cycle gates
were based on fluorescence, nuclear morphology, and
the presence of a bud [71]. For cells with a G2 DNA
content, those having a nuclear aspect ratio of 0.7 to 1
were classified as S/G2-phase cells, and those having a
ratio below 0.7 as mitotic cells.
Measurement of growth rates
Strains were grown in YPD rich medium. In liquid
medium, 2 μl of stationary phase cultures (40 to
48 hours) were diluted with 200 μl fresh YPD in 96-well
plates and grown at 30°C in a BMG Fluostar Optima
plate-reader. OD595 measurements were taken every
10 minutes to plot the growth curve, and a curve-fitting
algorithm written in R used to calculate the strain mini-
mum doubling time. Each tetraploid strain was grown in
triplicate and the average minimum doubling time was
calculated. The growth rate (proportional to the inverse
of the doubling time) relative to the WT was calculated
as the WT average minimum doubling time divided by
the average minimum doubling time for each strain.
For solid assays, the required drug or stress agent was
added to YPD-agar. Overnight cultures of the tetraploid
strains were spotted onto plates using a Singer rotor
HDA colony-pinning robot. Plates were incubated at
30C and photographed at 24 and 48 hours and analysed
using a custom-written image processing script in
MatLab (Mathworks). Colony size for each strain was
compared with both WT growth on the same plate and
with growth in the absence of drugs. This stressed : un-
stressed ratio was calculated for every strain on a plate,
and the standard deviation of all ratios calculated.
Strains having a stress: unstressed ratio greater than two
standard deviations from that of the WT were deemed
significantly resistant or sensitive. Hierarchical clustering
was performed both for the strains, and the different
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visualised using Java TreeView software. Pairwise correl-
ation coefficients were calculated to determine the simi-
larities between individual gene stress-response profiles.Additional files
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